RxDoctor Payments Data

Kevin Carrier

Medical · Los Angeles, CANPI 1407470438

Payments from drug & device makers

$5,187in general payments, 2019–2025

Across 217 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$802
  • Bard Peripheral Vascular, Inc.$416
  • Boehringer Ingelheim$354
  • Novartis$333
  • Shockwave Medical, Inc$320
  • Philips North America LLC$296
  • plus $3K from 28 others

What the payments were for

  • Food & beverage$5,168100%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,187 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan71$57,548
EliquisApixaban12$14,737
Repatha SureclickEvolocumab18$13,018
JardianceEmpagliflozin19$9,805
Rosuvastatin Calcium71$932
Potassium Chloride17$560
Bisoprolol Fumarate30$505
Furosemide36$443
Doxazosin Mesylate25$428
Chlorthalidone25$397
Spironolactone33$342
Valsartan19$317
Metoprolol Succinate13$241
Carvedilol15$181
Lisinopril25$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$333$57,54871 claims
PfizerEliquis$23$14,73712 claims
Boehringer IngelheimJardiance$354$9,80519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.

Other medical in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →